Epilepsy in the older patient

Reviews in Clinical Gerontology

Volumn 17, Issue 2, 2007, Pages 109-118

  Johnston, Ann ^a   Smith, Phil ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; DIGOXIN; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PREGABALIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; VITAMIN D; WARFARIN;

AGED; AGING; ALBUMIN BLOOD LEVEL; ALLERGIC RASH; ANAMNESIS; ANTICONVULSANT THERAPY; BEHAVIOR; BRADYKINESIA; BRADYPHRENIA; BRAIN SURGERY; CEREBROVASCULAR DISEASE; CLINICAL EXAMINATION; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GAIT DISORDER; GERIATRIC PATIENT; HUMAN; HYPONATREMIA; KIDNEY CLEARANCE; LIVER METABOLISM; MOOD; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING HOME; NURSING HOME PATIENT; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL EXAMINATION; PSYCHOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SOMNOLENCE; VAGUS NERVE STIMULATION; VITAMIN D METABOLISM;

EID: 44349157503     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259808002414     Document Type: Review

References (49)

1. Leppik IE. Introduction to the International Geriatric Epilepsy Symposium (IGES). Epilepsy Res 2006; S1-S4.
2. Hauser WA. Seizure disorders: the changes with age. Epilepsia 1992; 33(suppl 4): S6-S14.
3. Cockerell OC, Eckle I, Goodridge DM et al. Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry 1995; 58: 570-76.
4. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester Minnesota. Mayo Clin Proc 1996; 71: 576-86.
5. Stephen LS, Brodie MJ. Epilepsy in elderly people. Lancet 2000; 355: 1441-46.
6. Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005; 331: 1317-22.
7. Cloyd J, Hauser W, Towne A, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006; 68(suppl 1): S39-48.
8. Forsgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996; 37: 224-29.
9. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester Minnesota: 1935-1984. Epilepsia 1993; 34: 453-68.
10. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32: 429-45.
11. Schachter SC, Crammer WG, Thompson GD et al. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatric Soc 1998; 46, 1137-41.
12. Hopkins A, Garman A, Clarke C. The first seizure in adult life: value of clinical features, electroencephalography and computerised scanning in prediction of seizure recurrence. Lancet 1998; 331: 721-26.
13. Sander JW, Hart YM, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990; 336(8726): 1267-71.
14. Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004; 363: 1184-86.
15. Hesdorffer DC, Hauser WA, Annegers JF et al. Neurology 1996; 46: 727-30.
16. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62(suppl 2): S24-29.
17. Sheth RD, Drazkowski JF, Sirven JI, Gidal BE, Hermann BP. Protracted ictal confusion in elderly patients. Arch Neurol 2006; 63: 529-32.
18. Bottaro FJ, Martinex OA, Pardal MM, Bruetman JE, Reisin RC. Nonconvulsive status epilepticus in the elderly: a case-control study. Epilepsia 2007; 5: 966-72.
19. Van Cott AC. Epilepsy and the EEG in the elderly. Epilepsia 2002; 43(suppl 3): 94-102.
20. Sheorajpabday RVA, De Deyn PP. Epileptic fits and epilepsy in the elderly: general reflections, specific issues and therapeutic implications. Clin Neurol Neurosurg 2007 (in press).
21. Leppik IE, Brodie MJ, Saetre ER et al. Outcomes research: clinical trials in the elderly. Epilepsy Res 2006 (suppl 68): S71-76.
22. Marson A, Jacoby A, Johnson A et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 365: 2007-13.
23. Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004; 363: 1184-86.
24. Perucca E, Berlowitz D, Birnbaum A et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006(suppl 68S);S49-S63.
25. Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 2006; 45: 351-63.
26. Bernus I, Dickinson RG, Hooper WD, Eadie MJ. Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations. Drugs Aging 1997; 10: 278-89.
27. Leppik IE, Kelly KM, deToledo-Morrell L et al. Basic research in epilepsy and aging. Epilepsy Res 2006 (suppl 68S): S21-S37.
28. Gidal BE. Drug absorption in the elderly: Biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res 2006 (suppl 68S): S65-S69.
29. Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000-15.
30. Gillham R, Bryant-Comstock L, Kane K. Validation of the side-effect and life-satisfaction (SEALS) inventory. Seizure 2000; 9: 458-63.
31. Brodie MJ, Overstall PW, Giorgi L. The UK Lamotrigine Elderly Study Group. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37: 81-87.
32. Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016-26.
33. Garrard J, Harms S, Hardie N et al. Antiepileptic drug use in nursing home admissions. Ann Neurol 2003; 54: 75-85.
34. Huying F, Klimpe S, Werhahn K. Antiepileptic drug use in nursing home residents: a cross-sectional, regional study. Seizure 2006; 15: 194-97.
35. Birnbaum AK, Hardie NA, Conway JM et al. Phenytoin use in elderly nursing home residents. Am J Pharmacother 2003; 1: 90-95.
36. Birnbaum AK, Hardie NA, Leppik IE et al. Variability of multiple total phenytoin serum concentrations in elderly nursing home residents. Neurology 2003; 60: 555-59.
37. Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Zmendelson MA, Lawhorne L. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr. Soc 1998; 46: 1137-1141.
38. Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 2006; 13: 277-82.
39. Gallo BV. Epilepsy, surgery and the elderly. Epilepsy Res 2006; (suppl 68S): S83-S86.
40. Beghi E, Tomini C. Surgery for epilepsy: assessing evidence from observational studies. Epilepsy Res 2006; 70: 97-102.
41. Boon P, Vonck K, De RJ, Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure 2002; 11(suppl A): 448-55.
42. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol 1995; 12: 343-62.
43. Farhat G, Yamout B, Mikati MA et al. Effect of antiepileptic drugs on bone mineral density in ambulatory patients. Neurology 2002; 58: 1348-53.
44. Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL. Antiepileptic drug-use increases rates of bone loss in older women: a prospective study. Neurology 2004; 62: 2051-57.
45. Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004; suppl 2: S41-47.
46. Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav 2004; (suppl 2): S24-29.
47. Gaitatzis A, Carroll K, Majeed A, Sander JW. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004; 45: 1613-22.
48. Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999; 53(suppl. 2): S26-S32.
49. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs 2002; 16: 291-302.